Participants in the BEETHOVEN study will be randomized to receive two C. difficile vaccine doses six months apart, or a placebo, to learn if an investigational vaccine is safe and can help prevent C. difficile infection in people age 65 and older.

The conference provides a forum to highlight advances in the care of children and adults with congenital heart disease.

“These antibodies hold significant promise to be used in people who are at risk of measles, but who cannot respond to the measles vaccine due to their weakened immune systems," said James Crowe Jr., MD, whose research team isolated the human monoclonal antibodies.

A recent Vanderbilt Health Credo Award winner, he "is unwavering in his commitment to quality care for all populations."

In the program’s first year, the team distributed a frozen meal or box of nonperishable food items to 235 families in the hospital, with 98% of recipients saying the food was helpful.

Teen mental health, social media, bullying, screen time and school quality top list of parental concerns

Novel research is paving way for less invasive therapies for gliomas in pediatric patients.